| PI |
| Active, not recruiting | 4 | 22 | Europe | Opicapone, BIA 9-1067 | Bial - Portela C S.A. | Parkinson Disease | 06/23 | 06/23 | | |
| Active, not recruiting | 2b | 210 | Europe, US | Orismilast modified release tablets, Placebo | UNION therapeutics | Atopic Dermatitis, Skin Diseases | 01/24 | 02/24 | | |
| Terminated | 2 | 87 | Europe, Canada, US | HepTcell, Placebo | Altimmune, Inc., Altimmune, Inc | Hepatitis B, Chronic | 03/24 | 04/24 | | |
NCT05686239: A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS) |
|
|
| Recruiting | 2 | 234 | Europe, US, RoW | RL-007, Placebo | Recognify Life Sciences | Cognitive Impairment Associated With Schizophrenia (CIAS), Cognitive Impairment, Schizophrenia | 06/25 | 07/25 | | |
NCT06040346: Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed with Plasmodium Falciparum |
|
|
| Active, not recruiting | 2 | 60 | RoW | Meplazumab for Injection | Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd | Malaria | 08/25 | 10/25 | | |
TRAK-ER, NCT04985266 / 2020-004022-36: A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer |
|
|
| Recruiting | 2 | 1100 | Europe | Palbociclib 125Mg Tab, Fulvestrant injection, Tamoxifen, Letrozole, Exemestane, Anastrozole | Royal Marsden NHS Foundation Trust, Pfizer, AstraZeneca, Institute of Cancer Research, United Kingdom, UNICANCER, Gustave Roussy, Cancer Campus, Grand Paris, Invitae Corporation | ER+ Breast Cancer, HER2-negative Breast Cancer | 09/27 | 09/30 | | |
NCT05463263: A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas |
|
|
| Recruiting | 1/2 | 180 | Europe, US | STP938 | Step Pharma, SAS | Lymphoma, B-Cell, Lymphoma, T-Cell | 12/25 | 12/25 | | |
NCT05756322: The Safety and Tolerability of LBS-007 in Patients with Relapsed or Resistant Acute Leukaemias |
|
|
| Recruiting | 1/2 | 90 | US, RoW | LBS-007 | Lin BioScience, Inc, Lin BioScience Pty Ltd | Relapsed or Resistant Acute Leukaemias | 12/25 | 12/25 | | |
NCT04534686: CogXergaming to Promote Physical Activity and Cognitive Function in Frail Older Adults |
|
|
| Completed | N/A | 50 | US | CogXergaming, Cognitive training, Matter of Balance Training, Conventional training | University of Illinois at Chicago | Frail Older Adults | 12/22 | 03/23 | | |
NCT06261216: Association Between Lifetime Physical Activity and Exercise and the Development of Wild-type Transthyretin Amyloid Cardiomyopathy |
|
|
| Recruiting | N/A | 252 | Europe | Interview | Medical University of Graz, Medical University Innsbruck | Amyloid Cardiomyopathy, Wild Type ATTR Amyloidosis | 02/25 | 02/25 | | |
| Recruiting | N/A | 548 | Europe | Intervention | Interlinked AB, Parc Sanitari Sant Joan de Déu, Centro Hospitalar e Universitário de Coimbra, E.P.E. | Intravenous Access, Medical Device | 12/24 | 03/25 | | |
| |
| Active, not recruiting | 3 | 290 | Europe | Metformin Hydrochloride, Placebo Oral Tablet | Universiteit Antwerpen, University Hospital, Antwerp | Chronic Kidney Diseases | 12/24 | 12/24 | | |
| Recruiting | 2 | 200 | Europe | Pentaglobin®/Standard of Care | RWTH Aachen University, Biotest | Peritonitis, Sepsis, Septic Shock | 09/27 | 03/28 | | |
